In July 2023, the US Food and Drug Administration (FDA) approved Opill, a daily progestin-only oral contraceptive for over-the-counter sale to people of all ages. Daniel Grossman, MD, discusses this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH.

Related Content:

• Over-the-Counter Oral Contraceptives
• Over-the-Counter Oral Contraceptive Pills
• Over-the-Counter Progestin-Only Oral Contraceptives